Literature DB >> 22321961

The time course of flow-mediated vasodilation and endothelial dysfunction in patients with a cardiovascular risk factor.

Tomoyuki Kabutoya1, Satoshi Hoshide, Yukiyo Ogata, Tomohiko Iwata, Kazuo Eguchi, Kazuomi Kario.   

Abstract

The relationship between having a cardiovascular risk factor and endothelial dysfunction observed on a time-course analysis of brachial artery flow-mediated vasodilation (FMD) remains unclear. We enrolled 257 patients who had at least one cardiovascular risk factor. We measured FMD magnitude of the percentage change in peak diameter (ΔFMD), maximum FMD rate calculated as the maximum slope of dilation (FMD-MDR), and integrated FMD response calculated as the area under the dilation curve during the 60- and 120-second dilation periods (FMD-AUC60 and FMD-AUC120) using a semiautomatic edge-detection algorithm. FMD-AUC60 and FMD-AUC120 were negatively correlated with the Framingham risk score (FMD-AUC60: r = -0.15, P = .023; FMD-AUC120: r = -0.17, P = .007), whereas this association was not found in the case of either the ΔFMD or the FMR-MDR. The Framingham risk score was significantly higher in patients in the lowest tertile for FMD-AUC120 (FMD-AUC120 <5.0 mm × second) than in those in the highest tertile for FMD-AUC120 (FMD-AUC120 ≥11.0 mm × second) (12.9 ± 8.7 vs. 8.6 ± 7.8%, P = .002). The lowest tertile for FMD-AUC120 was independently associated with the Framingham risk score (β = 0.10, P = .011), after adjustments were made for age, gender, and smoking and drinking status. FMD-AUC120 was associated with cardiovascular risk. Copyright Â
© 2012 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22321961     DOI: 10.1016/j.jash.2011.11.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  10 in total

1.  Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Authors:  Akihiro Hirashiki; Shiro Adachi; Yoshihisa Nakano; Yoshihiro Kamimura; Shigetake Shimokata; Kyosuke Takeshita; Toyoaki Murohara; Takahisa Kondo
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

2.  The effects of topiroxostat on vascular function in patients with hyperuricemia.

Authors:  Shingo Higa; Daisuke Shima; Naoko Tomitani; Yoko Fujimoto; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-09-26       Impact factor: 3.738

3.  Hemodynamic arteriosclerotic syndrome - A vicious cycle of hemodynamic stress and vascular disease.

Authors:  Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-06       Impact factor: 3.738

4.  Relationship between endothelial dysfunction and kidney disease.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-12-12       Impact factor: 3.738

5.  Recovery of flow-mediated vasodilatation after repetitive measurements is involved in early vascular impairment: comparison with indices of vascular tone.

Authors:  Hatsumi Inaba; Kyosuke Takeshita; Yasuhiro Uchida; Motoharu Hayashi; Takahiro Okumura; Akihiro Hirashiki; Daiji Yoshikawa; Hideki Ishii; Koji Yamamoto; Takayuki Nakayama; Masaaki Hirayama; Hiroyuki Matsumoto; Tadashi Matsushita; Toyoaki Murohara
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

6.  Short telomere length is associated with renal impairment in Japanese subjects with cardiovascular risk.

Authors:  Kazuo Eguchi; Lawrence S Honig; Joseph H Lee; Satoshi Hoshide; Kazuomi Kario
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

7.  The area under curve for time-course analysis parameters is associated with abdominal aortic aneurysms and the severity of peripheral artery disease in men.

Authors:  Nao Konno; Taku Harada; Daijirou Akamatsu; Hitoshi Goto; Takashi Miki; Takashi Kamei; Masahiro Kohzuki
Journal:  Int J Cardiol Hypertens       Date:  2021-02-04

8.  Aggressive blood pressure-lowering therapy guided by home blood pressure monitoring improves target organ damage in hypertensive patients with type 2 diabetes/prediabetes.

Authors:  Kazuo Eguchi; Satoshi Hoshide; Shizukiyo Ishikawa; Kazuyuki Shimada; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-05-18       Impact factor: 3.738

9.  Masked hypertension defined by home blood pressure monitoring is associated with impaired flow-mediated vasodilatation in patients with cardiovascular risk factors.

Authors:  Tomoyuki Kabutoya; Satoshi Hoshide; Yukiyo Ogata; Kazuo Eguchi; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-06-25       Impact factor: 3.738

10.  Add-On Use of Eplerenone Is Effective for Lowering Home and Ambulatory Blood Pressure in Drug-Resistant Hypertension.

Authors:  Kazuo Eguchi; Tomoyuki Kabutoya; Satoshi Hoshide; Shizukiyo Ishikawa; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-13       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.